4, 5-diarylthiazole derivatives as cb-1 ligands

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/426 (2006.01) A61K 31/427 (2006.01) A61P 25/28 (2006.01) C07D 277/56 (2006.01) C07D 417/04 (2006.01) C07D 417/12 (2006.01)

Patent

CA 2511603

The present invention relates to compounds of formula (I): in which R1 and R2 independently represent phenyl, thienyl or pyridyl and R3represents a group -X- Y-NR4R5 in which X is CO or SO2; Y is absent or represents NH and the other substituente are as defined in the description and their use in the treatment of obesity, psychiatric and neurological disorders and to pharmaceutical compositions containing them.

L'invention concerne des composés de formule générale (I), dans laquelle R?1 ¿et R?2 ¿représentent indépendamment phényle, thiényle ou pyridyle et R?3 ¿représente un groupe -X-Y-NR?4¿R?5¿ dans lequel X est CO ou SO¿2?; Y est absent ou représente NH, les autres substituants ayant la signification indiquée dans la description; leur utilisation dans le traitement de l'obésité, de troubles psychiatriques et neurologiques; ainsi que des compositions pharmaceutiques les contenant.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

4, 5-diarylthiazole derivatives as cb-1 ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 4, 5-diarylthiazole derivatives as cb-1 ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4, 5-diarylthiazole derivatives as cb-1 ligands will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1376250

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.